Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7504109 immune cell study in healthy participants
NL-OMON60934Phase 1Completed
- Sponsor
- Roche
- Start
- Sep 2025
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1 trial of RO7504109, sponsored by Roche. Started Sep 2025; status: completed.
02
Drugs
RO7504109
Beyond the preview
Go deeper on NL-OMON60934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60934.